138 related articles for article (PubMed ID: 9571973)
1. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
2. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
[TBL] [Abstract][Full Text] [Related]
3. [Two cases of advanced breast cancer effectively treated with chemoendocrine therapy and radiotherapy].
Kimura M; Hagiwara S; Hirose K; Shimokawa Y; Iwai K; Uemura K
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2505-8. PubMed ID: 7944499
[TBL] [Abstract][Full Text] [Related]
4. [A case of complete remission of breast cancer with bilateral multiple lung metastases by combination therapy of MPA, THP, CPM and 5-FU].
Kusama M; Kimura K; Koyanagi Y; Kaise H; Arima M; Satoh Y; Murata J; Matsunaga T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):521-4. PubMed ID: 8452389
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
6. Eyelid metastasis from breast cancer showing marked response to chemotherapy.
Zhang GJ; Adachi I; Yin DF; Narabayashi M; Tokue Y; Watanabe T; Kaneko A; Tsuda H; Abe K
Jpn J Clin Oncol; 1995 Feb; 25(1):10-5. PubMed ID: 7877258
[TBL] [Abstract][Full Text] [Related]
7. [A case of giant advanced breast cancer responding remarkably to CEFT therapy].
Yano M; Kume K; Ono E; Wakasugi K; Matsuzaka T; Fujinaga H
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1067-70. PubMed ID: 8512336
[TBL] [Abstract][Full Text] [Related]
8. [Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers].
Okazaki M; Okazaki A; Masuoka H; Toda K; Yamada T; Okazaki Y; Asaishi K; Hirata K; Narimatsu E
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():94-101. PubMed ID: 7747999
[TBL] [Abstract][Full Text] [Related]
9. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
Satoh Y; Une Y; Fujisawa J; Uchino J
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
[TBL] [Abstract][Full Text] [Related]
10. [A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)].
Shimada K; Karaki Y; Ansai Y; Hino K; Yamashita Y; Fujimaki M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):623-6. PubMed ID: 8678522
[TBL] [Abstract][Full Text] [Related]
11. [Systemic therapy, pain relief and quality of life of breast cancer patients with bone metastasis].
Sonoo H; Shimozuma K; Kurebayashi J; Ohta K; Kiyono T
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():10-5. PubMed ID: 7747985
[TBL] [Abstract][Full Text] [Related]
12. [Chemo-endocrine therapy with high dose medroxyprogesterone acetate for recurrent or advanced breast cancer].
Maeda T; Kubo Y; Sasajima T; Ikeda K; Hirata S; Yamazaki K; Nakajima S
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2165-9. PubMed ID: 8239681
[TBL] [Abstract][Full Text] [Related]
13. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Toi M; Taniguchi T; Hayashi K; Tominaga T
Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
[TBL] [Abstract][Full Text] [Related]
14. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Noguchi S; Yamamoto H; Inaii H; Koyama H
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
[TBL] [Abstract][Full Text] [Related]
15. [Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer].
Mitsuyama S; Kuroda Y; Ohsato K; Nakamura Y; Murakami F; Nishikata F; Ikeda S; Egami T; Mori A; Ohe H
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1153-60. PubMed ID: 8751803
[TBL] [Abstract][Full Text] [Related]
16. [4-component chemotherapy and radiation therapy of breast cancer].
Gritsaĭ AA; Lichinitser MR; Vyshinskaia GV; Kondrat'eva AP; Aplevich NN
Ter Arkh; 1986; 58(9):105-8. PubMed ID: 3787480
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
[TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
Funahashi H; Sato Y; Imai T; Kato N; Ando K; Oike E; Odaka K; Ono M; Narita T; Kato M
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):689-92. PubMed ID: 2157371
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of CAF plus MPA with CAF plus TAM for advanced or recurrent breast cancer--Kyushu CAFT Study Group of Advanced or Recurrent Breast Cancer].
Mitsuyama S; Tashiro H; Koga T; Maehara Y; Ogawa M; Kakegawa T; Shimazu H; Sugimachi K; Tomita M; Nakamura Y
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2073-80. PubMed ID: 8607618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]